logo

For the Inventor, By the Inventor

Middlesex, United Kingdom

Glaxo Group Limited


USPTO Granted Patents = 1,169

% Expired Patents = 33.1



Trademarks = 850

Forward Citations = 17,009

Loading Chart...
Loading Chart...

1,328 inventors (with patents filed for the assignee):

goldMedal Paul Kenneth Rand (72 out of 92 patents)

silverMedal Alan Naylor (39 out of 65 patents)

bronzeMedal Ian H Coates (39 out of 41 patents)

4.  Harry Finch (37 out of 47 patents)

5.  Alexander W Oxford (37 out of 58 patents)

6.  John W Clitherow (35 out of 40 patents)

7.  John Bradshaw (34 out of 40 patents)

8.  Michael Birsha Davies (33 out of 37 patents)

9.  Keith Biggadike (31 out of 51 patents)

10.  Michael B Tyers (31 out of 31 patents)

11.  Anthony James Taylor (29 out of 30 patents)

12.  Lawrence H Lunts (29 out of 29 patents)

13.  Peter C North (26 out of 27 patents)

14.  Duncan B Judd (26 out of 26 patents)

15.  David E Bays (25 out of 29 patents)


Core Competencies:
Inhalation Device
Antigen Binding Proteins
Recombinant Proteins
Pharmaceutical Formulations
Muscarinic Receptor Antagonist
β-2 Adrenoreceptor Agonist
Autoimmune Diseases
Respiratory Tract Diseases
Fluid Dispenser
Dentine Hypersensitivity
Drug Dispenser
Oral Care Composition

1,169 patents:

1. D1104149 - Label set for an inhalation device (2025-12-02),
2. 12466893 - ANTIGEN BINDING PROTEINS (2025-11-11),
3. 12396986 - Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist (2025-08-26),
4. 11667887 - Method of producing a recombinant protein (2023-06-06),
5. 11419945 - Antigen binding proteins (2022-08-23),
6. D938521 - Label set for an inhalation device (2021-12-14),
7. 11116721 - Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol (2021-09-14),
8. 11090294 - Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist (2021-08-17),
9. 10946025 - Compounds (2021-03-16),
10. 10808040 - Modified proteins and peptides (2020-10-20),
11. 10808029 - Antigen binding proteins to oncostatin M (OSM) (2020-10-20),
12. 10703814 - Method of treatment with humanized anti-IL-18 antibodies (2020-07-07),
13. 10696738 - Anti-serum albumin binding variants (2020-06-30),
14. 10633673 - Production methods (2020-04-28),
15. 10624898 - Compounds (2020-04-21),
Glaxo Group Limited is a British multinational pharmaceutical company. It specializes in researching, developing, manufacturing, and marketing pharmaceutical medicines, vaccines, and consumer healthcare products. With a mission to help people do more, feel better, and live longer, GSK focuses on areas such as respiratory, vaccines, and HIV/AIDS. The company operates globally, aiming to improve the health and well-being of individuals around the world.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Glaxo Group Limited
1,169 Patents

#1 in Middlesex

#10 in United Kingdom

#878 in the World

Middlesex, GB
Middlesex, United Kingdom

Glaxo Group Limited

Forward Citations = 17,009

1,328 inventors:

goldMedal Paul Kenneth Rand (72 out of 92 patents)

silverMedal Alan Naylor (39 out of 65 patents)

bronzeMedal Ian H Coates (39 out of 41 patents)

4.  Harry Finch (37 out of 47 patents)

5.  Alexander W Oxford (37 out of 58 patents)

Please report any incorrect information to [email protected]
Loading…